Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ALR

Alere (ALR) Stock Price, News & Analysis

Alere logo

About Alere Stock (NYSE:ALR)

Advanced Chart

Key Stats

Today's Range
$1.32
$1.32
50-Day Range
N/A
52-Week Range
$34.41
$51.00
Volume
N/A
Average Volume
40,839 shs
Market Capitalization
$43.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

Receive ALR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alere and its competitors with MarketBeat's FREE daily newsletter.

ALR Stock News Headlines

Alro SA ALR
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
ABP Acquisition to Acquire AlerisLife for $1.31 Per Share
AlerisLife Inc. Announces Third Quarter 2022 Results
See More Headlines

ALR Stock Analysis - Frequently Asked Questions

Alere Inc. (NYSE:ALR) announced its earnings results on Friday, November, 4th. The medical research company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.54 by $0.35. Alere's quarterly revenue was down 3.6% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alere investors own include Morgan Stanley (MS), HeartBeam (BEAT), Abbott Laboratories (ABT), Edwards Lifesciences (EW), FireEye (FEYE), Twitter (TWTR) and AEGR (AEGR).

Company Calendar

Last Earnings
11/04/2016
Today
6/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Skilled nursing care facilities
Sub-Industry
Health Care Supplies
Current Symbol
NYSE:ALR
Employees
10,400
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$29.92 million
Pretax Margin
-5.29%

Debt

Sales & Book Value

Annual Sales
$934.59 million
Price / Cash Flow
N/A
Book Value
$5.72 per share
Price / Book
0.23

Miscellaneous

Free Float
29,870,000
Market Cap
$43.05 million
Optionable
Optionable
Beta
0.85
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:ALR) was last updated on 6/27/2025 by MarketBeat.com Staff
From Our Partners